Scarica l'app Stockscreener
6.3119
1.61%
0.1019
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.21
Aprire:
$6.26
Volume 24 ore:
520.97K
Relative Volume:
0.27
Capitalizzazione di mercato:
$647.78M
Reddito:
-
Utile/perdita netta:
$-54.65M
Rapporto P/E:
-4.8748
EPS:
-1.2948
Flusso di cassa netto:
$-49.47M
1 W Prestazione:
-1.41%
1M Prestazione:
+12.68%
6M Prestazione:
+13.49%
1 anno Prestazione:
+166.24%
Intervallo 1D:
$6.1219
$6.38
Intervallo di 1 settimana:
$6.02
$6.66
Portata 52W:
$2.25
$7.11
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
6.31 | 637.51M | 0 | -54.65M | -49.47M | -1.2948 |
VRTX
Vertex Pharmaceuticals Inc
|
486.82 | 126.50B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
666.55 | 69.50B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
908.20 | 56.92B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.46 | 43.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
192.94 | 40.34B | 742.00K | -1.37B | -1.07B | -7.0731 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Vivo Opportunity group reports 5.0% stake in Achieve Life Sciences | ACHV SEC FilingForm SCHEDULE 13G - Stock Titan
Achieve Life Sciences Joins Russell 2000 Index - 富途牛牛
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha
Achieve Life Sciences, Inc. Amends Certificate of Incorporation – SEC 8-K Filing Details and Company Information - Minichart
[8-K] ACHIEVE LIFE SCIENCES, INC. Reports Material Event - Stock Titan
ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits
ACHVAchieve Life Sciences Inc Latest SEC Filings - Finviz
Achieve Life Sciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Index - marketscreener.com
Achieve Life Sciences added to Russell 2000 index By Investing.com - Investing.com Nigeria
Achieve Life Sciences (ACHV) Joins Russell 2000 Index - GuruFocus
Achieve Life Sciences added to Russell 2000 index - Investing.com
Achieve Life Sciences Joins Russell 2000® Index - The Manila Times
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Index - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBIT forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to earnings forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Index - marketscreener.com
Price to sales forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBITDA forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to book forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Completeness Index - marketscreener.com
Achieve Life Sciences (ACHV) Receives Strong Buy Rating with $20 Target - GuruFocus
Raymond James resumes Achieve Life Sciences stock coverage with Strong Buy - Investing.com Canada
Achieve Life Sciences, Inc. Actuals & Estimates (NASDAQ:ACHV) - TradingView
Achieve Life Sciences, Inc. Actuals & Estimates (MUN:SP4P) - TradingView
ACHV Forecast — Price Target — Prediction for 2027 - TradingView
Achieve Life Sciences Inc (ACHV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Achieve Life Sciences (ACHV) Receives a Buy from Canaccord Genuity - The Globe and Mail
Canaccord reiterates Achieve Life Sciences stock rating after CRL By Investing.com - Investing.com India
Canaccord reiterates Achieve Life Sciences stock rating after CRL - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter By Investing.com - Investing.com India
Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish - Seeking Alpha
Achieve Life Sciences jumps despite cytisinicline CRL - MSN
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned - Sahm
Achieve Life Sciences (ACHV) Slips 1.76% as Stock Holds Above Key Support at $4.76Value Factor - dars.gov.et
Achieve Life Sciences (ACHV) Receives FDA Complete Response Lett - GuruFocus
Achieve Life Sciences stock falls after FDA issues response letter - Investing.com
ACHV Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus
Achieve Life Sciences (ACHV) Sees 10% Rise Despite FDA Complete Response Letter - GuruFocus
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug - Reuters
Achieve Life Sciences Shares Rise After Complete Response Letter From FDA - marketscreener.com
Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline - marketscreener.com
Achieve Life Sciences receives FDA rejection on manufacturing issues By Investing.com - Investing.com Nigeria
Achieve Life Sciences receives FDA rejection on manufacturing issues - Investing.com
La FDA américaine refuse d'autoriser le médicament anti-tabagique d'Achieve Life Sciences - TradingView
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
1.56%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):